Entrada Therapeutics director, 10% owner Kush Parmar disposes of $807,529 in common shares
TRDA•Parmar reports July share sales
Entrada Therapeutics director Kush Parmar reported sales of 116,474 shares on July 30-31, cutting 5AM Ventures V’s stake to 2,846,592 shares.
- The July 30 sale covered 114,756 shares at a weighted average price of $6.93.
- The July 31 sale covered 1,718 shares at $6.85.
- 5AM Opportunities I held 1,093,313 shares following the transactions.
